GINKGO BIOWORKS HOLDINGS, INC. Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 0 shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2025-11-06
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2024-09-30 was 5.57K shares.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2024 was 0.00 shares.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2022 was 19.43K shares.
- GINKGO BIOWORKS HOLDINGS, INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2021 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 9 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-06 | |||||||
| 2024-12-31 | 0.00 shares 10-K · filed 2025-02-25 | |||||||
| 2024-09-30 | 5.57K shares 10-Q · filed 2025-11-06 | 6.00K shares 10-Q · filed 2024-11-12 | 5.57K shares 10-Q · filed 2025-11-06 | 6.00K shares 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | 5.57K shares 10-Q · filed 2025-08-07 | 223.00K shares 10-Q · filed 2024-08-08 | 5.57K shares 10-Q · filed 2025-08-07 | 223.00K shares 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | 21.91K shares 10-Q · filed 2025-05-06 | 876.00K shares 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | 0.00 shares 10-K · filed 2025-02-25 | |||||||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | 1.67M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 19.43K shares 10-K · filed 2025-02-25 | 777.00K shares 10-K · filed 2024-02-29 | ||||||
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-29 |